Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
CGEM
CGEM News & Events
-
Add to Watchlist
Trade CGEM Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
CGEM News
Cullinan Therapeutics Reports Promising Clinical Data for CLN-978 and Velinotamig
Jun 10 2026
Newsfilter
Cullinan Therapeutics to Host Immunology Day with Key Updates
Jun 09 2026
NASDAQ.COM
CLN-978 Shows Significant Clinical Benefits in Autoimmune Diseases
Jun 06 2026
Newsfilter
Cullinan Receives FDA Orphan Drug Designation
May 19 2026
NASDAQ.COM
CLN-049 Receives FDA Orphan Drug Designation
May 19 2026
Newsfilter
Cullinan Therapeutics Presents Initial Clinical Data for CLN-978 at EULAR Congress
May 18 2026
Newsfilter
MindWalk Reports Significant Progress in Drug Development
May 18 2026
Newsfilter
Cullinan Therapeutics Reports Q1 Financial Results and Outlook
May 07 2026
seekingalpha
Show More News
CGEM Events
No data
CGEM Monitor News
No data
CGEM Earnings Analysis
No Data
People Also Watch
